Circle8 Group Inc. Receives Nasdaq Notice; Settles $35M Convertible Note

What Happened
Circle8 Group Inc. (CIRC) reported two material events in its Aug. 13, 2026 Form 8-K. Nasdaq notified the company that its common stock’s closing bid has been below the $1.00 minimum for 30 consecutive business days, triggering a formal deficiency notice and a cure period under Nasdaq rules. Separately, Circle8 (through Atlantic and related Lyneer entities) entered a settlement with SPP Credit Advisors that resolves pending litigation and cancels a $35,000,000 convertible promissory note tied to the Lyneer acquisition while addressing outstanding debt.

Key Details

• Nasdaq: Nasdaq sent a deficiency letter for violation of the $1.00 minimum bid-price rule after 30 consecutive business days below $1.00; Circle8 has a 180-calendar-day cure period (filing states a deadline of Feb. 9, 2026) to regain compliance, or potentially a second 180-day period; trading continues on the Nasdaq Global Market under ticker CIRC; company may consider a reverse stock split to regain compliance.
• Settlement financials: Total indebtedness to SPP was $62,669,730 as of Aug. 7, 2026. Atlantic agreed to issue 21,983,926 shares to SPP and SPP released a $35,000,000 convertible note (cancelled). SPP may sell the shares over an 18-month disposition period; indebtedness accrues interest at 5% per annum during that period.
• Other settlement terms: Atlantic may issue additional “legal fee shares” to cover SPP’s legal costs (capped at $1,800,000); Atlantic must file a prospectus supplement to register resale of the issued shares (failure triggers liquidated damages of 2% per month on covered shares); if share sales don’t fully repay SPP, Atlantic will issue an amended term note for remaining balance.
• Governance & operations: Lyneer Staffing will appoint Robert O. Riiska as Chief Transformation Officer; Lyneer Staffing’s board will be reconstituted with one Atlantic designee, one SPP designee and an independent director (initially Matthew Kahn). Refinancing and cash-flow provisions include efforts to refinance SLR debt within 45 days and a $5M payment to SPP upon refinancing; future capital-raise proceeds are allocated 20% (split between SPP and Employers HR, LLC) and 80% retained by Atlantic, with no proceeds to be used for employee bonuses.

Why It Matters
The Nasdaq deficiency notice creates a clear near-term regulatory risk: if Circle8 does not meet the minimum $1.00 bid-price cure conditions (or pursue other remedies like a reverse split), its shares could face delisting procedures. The settlement with SPP materially changes the company’s capital structure and legal overhang: it removes a $35M convertible seller note (which would have been dilutive if converted) but issues nearly 22 million shares to SPP and allows SPP to sell them over 18 months — a potential short-term overhang on the stock. The settlement also restructures debt obligations, sets interest and repayment mechanics, imposes registration and sales timing requirements, and alters Lyneer’s governance and operational controls, all of which may affect future cash flow, dilution, and investor returns.